Exact Sciences Raises $56M in IPO, But Analysts Still Cautious | GenomeWeb

NEW YORK, Jan 31 – Worried that Wall Street had completely turned its back on genomics companies, some investors — and executives — may be breathing a sigh of relief after applied genomics company Exact Sciences raised $56 million in an initial public offering on Wednesday.

In appraising the IPO climate some analysts noted that since the end of December, stock prices have begun to creep up out of the cellar, giving investors and companies alike a bit more confidence.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.